US Broker Ratings

Cytokinetics, Inc. (CYTK) Stock Analysis: Exploring a 36.40% Potential Upside in the Biotechnology Sector

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is capturing attention with its ambitious focus on developing innovative treatments targeting muscle-related diseases. With a market capitalization of..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 23% Potential Upside in the Biotech Arena

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a pivotal player in the biotechnology industry, with a strong focus on the development of RNA-targeted therapeutics and gene therapy for rare diseases...

BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth Amidst Strong Revenue Surge

BrightSpring Health Services, Inc. (BTSG), a prominent player in the healthcare sector, is capturing investor attention with its robust revenue growth and strategic positioning in the Health Information Services industry...

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Navigating Zero Upside but Strong Cash Flow

As Soleno Therapeutics, Inc. (NASDAQ: SLNO) continues to make strides in the healthcare sector, particularly within the biotechnology industry, investors are taking a closer look at its financial and performance..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Healthcare Innovator with 26% Potential Upside

In the rapidly evolving healthcare sector, Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves with its innovative approach to treating obstructive sleep apnea (OSA). The company’s flagship product, the..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook Reveals 56% Potential Upside Amid Robust Revenue Growth

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention with its compelling potential upside of 56.48%, driven by its innovative approach in the biotechnology sector. As a commercial-stage biopharmaceutical company,..

Glaukos Corporation (GKOS) Stock Analysis: Unpacking a 49.49% Potential Upside in the Medical Devices Sector

Investors seeking opportunities within the healthcare sector should take a closer look at Glaukos Corporation (NYSE: GKOS), a notable player in the medical devices industry. With a market capitalization of..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Riding the Wave of a 57% Potential Upside

For investors with an eye on the healthcare sector, iRhythm Holdings, Inc. (NASDAQ: IRTC) presents a compelling opportunity. Specializing in digital healthcare, iRhythm is at the forefront of integrating technology..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 38% Upside Potential Despite Recent Challenges

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the global healthcare sector, has been a staple in the plasma-derived medicines market for over a century. Headquartered in Barcelona, Spain, Grifols..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Promising 112% Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX) presents a compelling opportunity for investors with its innovative approach in the biotechnology sector. Specializing in vaccine development, this clinical-stage company is on the forefront of..

BioMarin Pharmaceutical Inc. (BMRN): Analyst Consensus Suggests a 53% Upside for a Biotech Innovator

BioMarin Pharmaceutical Inc. (BMRN), a prominent player in the biotechnology sector, continues to capture investor interest with its robust pipeline and strategic focus on therapies for rare diseases. With a..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on a High-Growth Biotech with 15% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its innovative approach to central nervous system (CNS) disorders. With a market capitalization of $12.07 billion, this..

Biogen Inc. (BIIB) Stock Analysis: A Closer Look at Its 11.96% Upside Potential

Biogen Inc. (BIIB), a prominent player in the healthcare sector, specifically within the drug manufacturing industry, presents a compelling case for investors with its robust portfolio and strategic collaborations. With..

Lantheus Holdings, Inc. (LNTH) Investor Outlook: High Buy Ratings and Promising Growth Prospects

For investors keeping an eye on the healthcare sector, Lantheus Holdings, Inc. (NASDAQ: LNTH) presents a compelling case with its strong market positioning in the specialty drug manufacturing industry. Notably,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 21% Potential Upside Amid Strong Buy Ratings

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands as a compelling player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $15.92 billion,..

Oscar Health, Inc. (OSCR) Stock Analysis: Evaluating the Healthcare Tech Innovator’s Growth Trajectory

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology landscape, has been attracting significant attention from investors, thanks to its impressive revenue growth and innovative approach to..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating the 8% Potential Upside Amidst Mixed Performance Metrics

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, presents a mixed bag of metrics that investors should carefully consider...

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Powerhouse with 31.90% Revenue Growth and Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a dynamic player within the biotechnology sector, carving its niche with groundbreaking genetic medicines aimed at treating diseases with significant unmet medical needs. With..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring a 12.47% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a heavyweight in the diagnostics and research industry with a market capitalization of $23.86 billion, is a company that continues to capture the attention of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds